SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as investors aggressively position themselves for long-term AI infrastructure expansion, fueled by reports of surging server demand and high-profile partnerships. The market is closely watching the company's enterprise adoption rates and its integration into massive on-premise AI deployments, with community sentiment split between excitement over a structural growth supercycle and concerns about whether current valuation levels have moved ahead of underlying fundamentals.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space Inc is drawing significant community attention as investors debate its long-term viability, potential share dilution, and the impact of leadership disputes following a recent private placement investment. While some bulls are betting on a recovery fueled by excitement around the broader space sector and upcoming high-profile industry events, skeptics are expressing concerns over financial transparency, the lack of immediate revenue, and potential insider selling.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing a parabolic price surge driven by heavy institutional momentum, derivative-linked buying, and speculation surrounding its strategic role in Nvidias new AI-focused CPU architecture. While the stock has reached all-time highs, the community remains sharply divided between investors celebrating a historic squeeze and critics highlighting extreme valuation concerns, high levels of insider selling, and the risks of a potential reversal.

Tema ETF Trust - Tema Space Innovators ETF

The Tema Space Innovators ETF (NASA) is gaining significant traction as investors look for indirect exposure to the highly anticipated SpaceX IPO and broader space sector growth. The community is actively debating the fund's unique portfolio, which features notable space infrastructure companies alongside a strategic allocation to SpaceX.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The Dow Jones Industrial Average is hitting record highs as the broader market finds resilience, driven by strong earnings in AI and semiconductor sectors. Despite community concerns regarding high inflation, geopolitical tensions, and consumer pessimism, investors are debating whether this momentum reflects genuine economic strength or a vulnerable, bubble-like environment.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending due to the announcement of a 300 million dollar share buyback alongside recent quarterly results, which has sparked intense community discussion about the company's path toward a potential US exchange relisting. Investors are actively debating the significance of the buyback as a sign of institutional confidence versus its impact on short-term price volatility and long-term valuation.

Futu Holdings Ltd. engages in the provision of digitalized financial services. It offers securities brokerage and wealth management products. The company was founded by Leaf Hua Li in December 2007 and is headquartered in Hong Kong.

Futu Holdings Ltd - ADR

Futu Holdings is trending as investors weigh strong quarterly growthdriven by global account expansion and increased trading volumesagainst a regulatory crackdown from Beijing regarding unlicensed cross-border activities. While the community is actively debating the severity of the proposed penalties versus the company's international growth trajectory, many traders are closely monitoring price volatility and upcoming earnings reports.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is seeing heightened community focus ahead of the upcoming AACR meeting, where investors anticipate updates on clinical trial data and potential trial enrollment milestones. The community remains highly bullish, citing strong insider holdings and positive preclinical immune response signals as primary catalysts for future re-rating.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as investors weigh strong prescription growth for its fibromyalgia drug against concerns over continued stock dilution and the recent approval of a reverse split authorization. Community sentiment is deeply polarized, with bulls pointing to expanding insurance coverage and institutional accumulation as signs of long-term upside, while bears express frustration over persistent share issuance and the company's historical performance.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is seeing intense investor debate as a segment of the community views the stock as a prime short candidate due to perceived AI-driven obsolescence, while supporters emphasize the company's strong user growth, significant cash reserves, and aggressive buyback program as evidence of long-term value. The stock remains highly volatile, frequently experiencing sharp intraday price swings that fuel active discussions among retail traders regarding its viability as a long-term software play versus a potential target for market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OMER Stock Gains Ground As Commercial Rollout Of Yartemlea Exceeds Expectations  

Equity

Yartemlea net sales in Q1 came in at $9.9 million, higher than the $4.1 million expected by Wall Street. 


Omeros Corporation Reports First Quarter 2026 Financial Results

Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2026, which include: First Quarter and Recent...

Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026

Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss...

Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway

Medical Products stocks face tariff and cost pressures, but Phibro Animal Health and peers leverage innovation, AI and demand trends to drive growth.

Omeros (NASDAQ:OMER) Trading 6.3% Higher - Should You Buy?

Omeros (NASDAQ:OMER) Stock Price Up 6.3% - Should You Buy...

Here's Why Omeros (OMER) is a Great Momentum Stock to Buy

Does Omeros (OMER) have what it takes to be a top stock pick for momentum investors? Let's find out.

Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade

The consensus price target hints at a 222.8% upside potential for Omeros (OMER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

4 Medical Product Stocks to Buy From a Challenging Industry

The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. PAHC, BLFS, OMER and BWAY reflect the favorable fundamentals.

Omeros (NASDAQ:OMER) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen lowered Omeros from a "buy" rating to a "hold" rating in a research note on Sunday...

D. Boral Capital Reiterates "Buy" Rating for Omeros (NASDAQ:OMER)

D. Boral Capital reissued a "buy" rating and issued a $36.00 price objective on shares of Omeros in a research note on Tuesday...

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

OMER
Omeros Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest OMER News

OMEROmeros Corp